Downregulation of CD166 inhibits invasion, migration, and EMT in the radio-resistant human nasopharyngeal carcinoma cell line CNE-2R

References

• MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet (London, England). 2016;387(10022):1012–1024.
   Google Scholar
• Tang LL, Chen WQ, Xue WQ, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374(1):22–30. doi:10.1016/j.canlet.2016.01.04026828135
   PubMed Web of Science ®Google Scholar
• Qu S, Liang ZG, Zhu XD. Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2015;16(5):1687–1692. 25773811
   PubMedGoogle Scholar
• Zheng LS, Yang JP, Cao Y, et al. SPINK6 promotes metastasis of nasopharyngeal carcinoma via binding and activation of epithelial growth factor receptor. Cancer Res. 2017;77(2):579–589. doi:10.1158/0008-5472.CAN-16-128127671677
   PubMed Web of Science ®Google Scholar
• Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21–45. doi:10.1016/j.cell.2016.06.02827368099
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890. doi:10.1016/j.cell.2009.11.00719945376
   PubMed Web of Science ®Google Scholar
• Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131–142. doi:10.1038/nrm183516493418
   PubMed Web of Science ®Google Scholar
• Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell. 2016;27(21):3233–3244. doi:10.1091/mbc.E16-01-005827582386
   PubMed Web of Science ®Google Scholar
• Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68(18):3033–3046. doi:10.1007/s00018-011-0735-121637948
   PubMed Web of Science ®Google Scholar
• Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15:18. doi:10.1186/s12943-016-0502-x26905733
   PubMed Web of Science ®Google Scholar
• Oh BY, Kim SY, Lee YS, et al. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget. 2016;7(35):57066–57076. doi:10.18632/oncotarget.1097427494849
   PubMedGoogle Scholar
• Kidd ME, Shumaker DK, Ridge KM. The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol. 2014;50(1):1–6. doi:10.1165/rcmb.2013-0314TR23980547
   PubMed Web of Science ®Google Scholar
• Chen ZT, Li L, Guo Y, et al. Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2. Oncol Rep. 2015;34(5):2477–2488. doi:10.3892/or.2015.425526352878
   PubMed Web of Science ®Google Scholar
• Lin H, Chen ZT, Zhu XD, et al. Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Oncotarget. 2017;8(38):62858–62867. doi:10.18632/oncotarget.1639928968954
   PubMedGoogle Scholar
• Guo Y, Zhu XD, Qu S, et al. Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein–protein interaction networks. Int J Oncol. 2012;40(1):85–92. doi:10.3892/ijo.2011.117221874234
   PubMed Web of Science ®Google Scholar
• Bowen MA, Patel DD, Li X, et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med. 1995;181(6):2213–2220. 7760007
   PubMed Web of Science ®Google Scholar
• Kristiansen G, Pilarsky C, Wissmann C, et al. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate. 2003;54(1):34–43. doi:10.1002/pros.1016112481253
   PubMed Web of Science ®Google Scholar
• Kristiansen G, Pilarsky C, Wissmann C, et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol. 2005;205(3):359–376. doi:10.1002/path.167615532095
   PubMed Web of Science ®Google Scholar
• Tachezy M, Effenberger K, Zander H, et al. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients. Int J Cancer. 2012;131(2):396–405. doi:10.1002/ijc.2637721858815
   PubMed Web of Science ®Google Scholar
• Verma A, Shukla NK, Deo SV, Gupta SD, Ralhan R. MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology. 2005;68(4–6):462–470. doi:10.1159/00008698916024937
   PubMed Web of Science ®Google Scholar
• Burkhardt M, Mayordomo E, Winzer KJ, et al. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol. 2006;59(4):403–409. doi:10.1136/jcp.2005.02820916484444
   PubMed Web of Science ®Google Scholar
• Hein S, Muller V, Kohler N, et al. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue. Breast Cancer Res Treat. 2011;129(2):347–360. doi:10.1007/s10549-010-1219-y20972617
   PubMed Web of Science ®Google Scholar
• Piao D, Jiang T, Liu G, Wang B, Xu J, Zhu A. Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer. Mol Biol Rep. 2012;39(1):661–668. doi:10.1007/s11033-011-0783-521670959
   PubMed Web of Science ®Google Scholar
• Zakaria N, Yusoff NM, Zakaria Z, et al. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells. BMC Cancer. 2015;15:84. doi:10.1186/s12885-015-1584-325881239
   PubMed Web of Science ®Google Scholar
• Satar NA, Fakiruddin KS, Lim MN, et al. Novel triplepositive markers identified in human nonsmall cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics. Oncol Rep. 2018;40(2):669–681. doi:10.3892/or.2018.646129845263
   PubMed Web of Science ®Google Scholar
• Weichert W, Knosel T, Bellach J, Dietel M, Kristiansen G. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol. 2004;57(11):1160–1164. doi:10.1136/jcp.2004.01623815509676
   PubMed Web of Science ®Google Scholar
• Shafaei S, Sharbatdaran M, Kamrani G, Khafri S. The association between CD166 detection rate and clinicopathologic parameters of patients with colorectal cancer. Caspian J Intern Med. 2013;4(4):768–772. 24294471
   PubMedGoogle Scholar
• van Kilsdonk JW, Takahashi N, Weidle U, et al. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma. J Invest Dermatol. 2012;132(5):1462–1470. doi:10.1038/jid.2011.48722318386
   PubMed Web of Science ®Google Scholar
• van Kempen LC, van Den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, Swart GW. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol. 2000;156(3):769–774. doi:10.1016/S0002-9440(10)64943-710702391
   PubMed Web of Science ®Google Scholar
• Blanco D, Vicent S, Elizegi E, et al. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest. 2004;84(8):999–1012. doi:10.1038/labinvest.370012915195114
   PubMed Web of Science ®Google Scholar
• Sanchez-Tillo E, Lazaro A, Torrent R, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene. 2010;29(24):3490–3500. doi:10.1038/onc.2010.10220418909
   PubMed Web of Science ®Google Scholar
• Wang H, Wu Q, Zhang Y, Zhang HN, Wang YB, Wang W. TGF-beta1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin. Cell Mol Biol Lett. 2017;22:22. doi:10.1186/s11658-017-0053-129118814
   PubMed Web of Science ®Google Scholar
• Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta. 1994;1198(1):11–26. 8199193
   PubMed Web of Science ®Google Scholar
• Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000;148(4):779–790. 10684258
   PubMed Web of Science ®Google Scholar
• Zuo J, Ishikawa T, Boutros S, Xiao Z, Humtsoe JO, Kramer RH. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis. Mol Cancer Res. 2010;8(2):170–182. doi:10.1158/1541-7786.MCR-09-035420145039
   PubMed Web of Science ®Google Scholar
• Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007;313(10):2050–2062. doi:10.1016/j.yexcr.2007.03.04017512929
   PubMed Web of Science ®Google Scholar
• Hwang WL, Yang MH, Tsai ML, et al. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology. 2011;141(1):279–291, 291.e271–275. doi:10.1053/j.gastro.2011.04.008
   PubMed Web of Science ®Google Scholar